1. Home
  2. MREO vs BHST Comparison

MREO vs BHST Comparison

Compare MREO & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MREO
  • BHST
  • Stock Information
  • Founded
  • MREO 2015
  • BHST 2007
  • Country
  • MREO United Kingdom
  • BHST Canada
  • Employees
  • MREO N/A
  • BHST N/A
  • Industry
  • MREO Biotechnology: Pharmaceutical Preparations
  • BHST
  • Sector
  • MREO Health Care
  • BHST
  • Exchange
  • MREO Nasdaq
  • BHST Nasdaq
  • Market Cap
  • MREO N/A
  • BHST N/A
  • IPO Year
  • MREO N/A
  • BHST N/A
  • Fundamental
  • Price
  • MREO $2.92
  • BHST $5.55
  • Analyst Decision
  • MREO Strong Buy
  • BHST Strong Buy
  • Analyst Count
  • MREO 6
  • BHST 2
  • Target Price
  • MREO $7.83
  • BHST $13.00
  • AVG Volume (30 Days)
  • MREO 1.2M
  • BHST 5.1K
  • Earning Date
  • MREO 02-13-2025
  • BHST 02-15-2025
  • Dividend Yield
  • MREO N/A
  • BHST N/A
  • EPS Growth
  • MREO N/A
  • BHST N/A
  • EPS
  • MREO N/A
  • BHST N/A
  • Revenue
  • MREO $1,000,000.00
  • BHST $22,430,000.00
  • Revenue This Year
  • MREO N/A
  • BHST $140.81
  • Revenue Next Year
  • MREO $54.47
  • BHST $120.86
  • P/E Ratio
  • MREO N/A
  • BHST N/A
  • Revenue Growth
  • MREO N/A
  • BHST 111.68
  • 52 Week Low
  • MREO $2.53
  • BHST $0.00
  • 52 Week High
  • MREO $5.02
  • BHST $7.38
  • Technical
  • Relative Strength Index (RSI)
  • MREO 33.84
  • BHST N/A
  • Support Level
  • MREO $2.80
  • BHST N/A
  • Resistance Level
  • MREO $3.39
  • BHST N/A
  • Average True Range (ATR)
  • MREO 0.23
  • BHST 0.00
  • MACD
  • MREO -0.07
  • BHST 0.00
  • Stochastic Oscillator
  • MREO 11.54
  • BHST 0.00

About BHST BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

Share on Social Networks: